Fujian Haixi Pharmaceuticals Co., Ltd. (stock code: 02637) released its monthly return for the period ended January 31, 2026. According to the announcement, the total authorized share capital remained at RMB 78,707,270, with ordinary H shares accounting for 78,707,270 shares at RMB 1 each.
The number of fully issued shares—78,707,270—remained unchanged from the previous month, while there were no treasury shares. The company confirmed continued compliance with the applicable public float requirement. The announcement also indicated that there were no share options, warrants, convertible securities, or other arrangements to issue new shares during the reporting period.
Comments